A5022777557- Influenza Virus Research Studies
- COVID-19 epidemiological studies
- Vaccine Coverage and Hesitancy
- Respiratory viral infections research
- Viral Infections and Outbreaks Research
- COVID-19 Pandemic Impacts
- COVID-19 and Mental Health
- SARS-CoV-2 and COVID-19 Research
National Center for Immunization and Respiratory Diseases
2022-2024
Centers for Disease Control and Prevention
2023-2024
CDC Foundation
2024
Center for Surveillance, Epidemiology, and Laboratory Services
2022
AID Atlanta
2022
Abstract Background Healthcare workers (HCWs) are an important target group for COVID-19 vaccination. In February 2021, Peru launched a vaccination campaign among HCWs using BBIBP-CorV inactivated whole-virus vaccine (Sinopharm). We aim to understand risk factors SARS-CoV-2 infection after cohort of in two hospitals Lima, Peru. Methods Between August 2021-June 2022, HCW who received at least Sinopharm doses were enrolled the and followed 6 months. Participants provided self-collected nasal...
To reduce influenza-associated morbidity and mortality, countries in South America recommend annual influenza vaccination for persons at high risk severe illness, including young children, with preexisting health conditions, older adults. Interim estimates of vaccine effectiveness (VE) from Southern Hemisphere can provide early information about the protective effects help guide Northern advance their season. Using data a multicountry network, investigators estimated interim VE against acute...
The COVID-19 pandemic has affected influenza virus transmission, with historically low activity, atypical timing, or altered duration of seasons during 2020-22 (1,2). Community mitigation measures implemented since 2020, including physical distancing and face mask use, have, in part, been credited for detections globally the pandemic, compared those prepandemic (1). Reduced population exposure to natural infections 2020-21 relaxed community after introduction vaccines could increase...
Although healthcare personnel (HCP) are targeted for influenza vaccination they typically underutilize vaccines especially in low- and middle-income countries. We explored knowledge, attitudes, practices of HCP about seasonal (SIV) to identify factors associated with modifiable barriers SIV uptake.
While vaccination is the most effective way to prevent influenza infection and adverse outcomes, despite WHO recommendations vaccinate pregnant persons, access seasonal vaccines remains low. We explored knowledge, attitudes, practices of persons about inform actions improve vaccine uptake among this priority population.
The COVID-19 pandemic has affected influenza virus transmission, with historically low activity, atypical timing, or altered duration of seasons during 2020–22.1Olsen SJ Azziz-Baumgartner E Budd AP et al.Decreased activity the pandemic—United States, Australia, Chile, and South Africa, 2020.MMWR Morb Mortal Wkly Rep. 2020; 69 (doi:10.15585/mmwr.mm6937a6): 1305-1309Crossref PubMed Scopus (281) Google Scholar,2Merced-Morales A Daly P Abd Elal AI al.Influenza composition 2022–23 vaccine—United...
COVID-19 vaccine effectiveness (VE) studies leveraging systematic surveillance in sub-Saharan Africa are limited. We assessed the of two vaccines (Pfizer BNT162b2 and Johnson & Ad26.COV2.S) against SARS-CoV-2-associated hospitalization South African adults aged ≥18 years.
Despite a longstanding Israel Ministry of Health recommendation that all healthcare personnel (HCP) receive seasonal influenza vaccine, vaccine uptake among HCP remains below the country's target 60% coverage. To understand factors related to hesitancy, we used data from prospective three-year (2016–2019) effectiveness study Israeli examine knowledge, attitudes, and practices (KAP) about vaccination their association with uptake. At start each season, participating completed questionnaire...